SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC the metals company Inc. is experiencing significant investor attention following recent U.S. regulatory advancements, including modernized deep-sea mining permits and an upcoming Congressional hearing featuring its CEO. The community is highly optimistic, interpreting these moves as strong government alignment to expedite critical mineral recovery for national security, anticipating substantial upside for the company.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is dominating financial discussions after Chairman Ryan Cohen expanded his stake, acquiring an additional 500,000 shares. This bold insider buy has ignited fervent community speculation about a potential market catalyst, renewing hopes for a significant move in the high short interest stock. While some express frustration over muted price action, many view Cohen's increasing ownership as a definitive signal of underlying value and a potential turning point.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing an extraordinary rally, driven by analyst upgrades and surging demand for memory and data storage in the AI infrastructure sector, notably influenced by Nvidia's new chip requirements. This rapid ascent has ignited fierce debate within the community, with many celebrating its "unstoppable" momentum while an equally vocal segment warns of an unsustainable "bubble" and impending correction.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging due to promising long-term follow-up data for its personalized cancer vaccine for melanoma, developed in partnership with Merck, which has shown sustained improvement in patient outcomes. This breakthrough is fueling widespread community discussion about the transformative potential for cancer treatment, a significant new revenue stream, and strong speculation around the stock being undervalued and poised for substantial upside or even a buyout, intensifying a short squeeze.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending following a significant licensing deal with Pfizer, which is widely seen as a major validation for its Matrix-M adjuvant technology. This news has ignited intense community discussion around the stock's substantial short interest, with many anticipating a potential squeeze and predicting further partnerships that could establish Matrix-M as a pivotal asset in the vaccine industry.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is trending strongly, demonstrating remarkable resilience and outperformance compared to peers like NVIDIA and Intel, even amidst broader market weakness. This momentum is driven by growing community conviction in AMD's increasing market share within the burgeoning AI and data center sectors, ahead of anticipated earnings. While many celebrate its upward trajectory and foresee new highs, some investors caution about potential overvaluation and a possible bull trap.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending due to its recent strategic partnership with Primary Digital Infrastructure to develop a significant AI data center campus in West Texas, alongside the finalization of a key acquisition. The community is actively discussing an imminent hyperscale tenant announcement, fueling speculation about major tech firms and the potential for a short squeeze within the rapidly expanding AI infrastructure sector.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a significant surge ahead of its upcoming quarterly report, fueled by recent analyst upgrades, growing optimism for its turnaround strategy, and strong demand for server CPUs. The community is abuzz with speculation regarding potential major partnerships and government contracts, leading to intense debates about whether the positive news is already priced in or if a further breakout is imminent. This renewed confidence highlights Intel's strategic importance in domestic chip manufacturing and its progress in advanced process technology.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed (PAVM) is trending after its subsidiary, Lucid Diagnostics, secured a significant U.S. Department of Veterans Affairs contract for its EsoGuard Esophageal DNA Test. This news has ignited intense community debate, with discussions centered on the stock's low float and high volatility, alongside speculation about short squeeze potential versus concerns over dilution and profit-taking. Traders are actively evaluating the contract's long-term valuation impact amid rapid price movements.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending as a clear FDA resubmission pathway for ANKTIVA in bladder cancer, coupled with recent Saudi FDA approval for lung cancer, de-risks its regulatory future. The community is highly engaged, actively discussing a potential short squeeze fueled by rapidly increasing cost-to-borrow rates and a strong conviction in the company's revolutionary cancer therapies, particularly as key figures hint at broader awareness initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promising Pharmaceutical Stocks To Add to Your Watchlist - January 21st

Eli Lilly and Company, AbbVie, and Novo Nordisk A/S are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly...

Top Medical Stocks To Follow Now - January 21st

Eli Lilly and Company, UnitedHealth Group, Johnson & Johnson, AbbVie, and Novo Nordisk A/S are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks...

FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate

Eli Lilly wins FDA Breakthrough Therapy status for sofetabart mipitecan in certain patients with platinum-resistant ovarian cancer.

Lilly confirms date and conference call for fourth-quarter 2025 financial results announcement

Lilly confirms date and conference call for fourth-quarter 2025 financial results announcement Lilly confirms date and conference call for fourth-quarter 2025 financial results announcement PR...

Rakuten Investment Management Inc. Makes New Investment in Eli Lilly and Company $LLY

Rakuten Investment Management Inc. bought a new stake in Eli Lilly and Company (NYSE:LLY - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange...

Eli Lilly and Company $LLY Shares Bought by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH raised its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 8.6% in the third quarter, according to its most recent 13F filing...

Migdal Insurance & Financial Holdings Ltd. Has $137.37 Million Stock Holdings in Eli Lilly and Company $LLY

Migdal Insurance & Financial Holdings Ltd. raised its stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 9.3% during the third quarter, according to its most recent disclosure with...

Joel Isaacson & Co. LLC Acquires 3,976 Shares of Eli Lilly and Company $LLY

Joel Isaacson & Co. LLC grew its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 57.9% during the 3rd quarter, according to its most recent filing with the Securities and...

Middleton & Co. Inc. MA Has $9.24 Million Stock Holdings in Eli Lilly and Company $LLY

Middleton & Co. Inc. MA raised its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 1,693.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund...

Dynasty Wealth Management LLC Sells 3,206 Shares of Eli Lilly and Company $LLY

Dynasty Wealth Management LLC lowered its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 77.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The...

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

LLY
Lilly(Eli) & Co

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest LLY News

LLYLilly(Eli) & Co